Rivero EM - Search Results

1

Anaphylaxis due to green beans (Phaseolus vulgaris): a new phenotype?

Rivero EM, Castaño MP, Romero IMD, Martínez MJM, Losa FP. Rivero EM, et al. Allergol Immunopathol (Madr). 2025 Jan 1;53(1):8-11. doi: 10.15586/aei.v53i1.1176. eCollection 2025. Allergol Immunopathol (Madr). 2025. PMID: 39786870

2

The Beta2-adrenergic agonist salbutamol synergizes with paclitaxel on cell proliferation and tumor growth in triple negative breast cancer models.

Jabloñski M, Rodríguez MS, Rivero EM, Bruque CD, Vanzulli S, Bruzzone A, Pérez Piñero C, Lüthy IA. Jabloñski M, et al. Among authors: rivero em. Cancer Chemother Pharmacol. 2023 Dec;92(6):485-499. doi: 10.1007/s00280-023-04586-9. Epub 2023 Sep 19. Cancer Chemother Pharmacol. 2023. PMID: 37725114

3

Adrenergic receptors in breast cancer.

Pérez Piñero C, Rivero EM, Gargiulo L, Rodríguez MS, Bruque CD, Bruzzone A, Lüthy IA. Pérez Piñero C, et al. Among authors: rivero em. Prog Mol Biol Transl Sci. 2022;193(1):37-63. doi: 10.1016/bs.pmbts.2022.06.002. Epub 2022 Jul 11. Prog Mol Biol Transl Sci. 2022. PMID: 36357079

4

Agonist Effects of Propranolol on Non-Tumor Human Breast Cells.

Gargiulo L, Rivero EM, di Siervi N, Buzzi ED, Buffone MG, Davio CA, Lüthy IA, Bruzzone A. Gargiulo L, et al. Among authors: rivero em. Cells. 2020 Apr 22;9(4):1036. doi: 10.3390/cells9041036. Cells. 2020. PMID: 32331276 Free PMC article.

5

Prognostic significance of α- and β2-adrenoceptor gene expression in breast cancer patients.

Rivero EM, Martinez LM, Bruque CD, Gargiulo L, Bruzzone A, Lüthy IA. Rivero EM, et al. Br J Clin Pharmacol. 2019 Sep;85(9):2143-2154. doi: 10.1111/bcp.14030. Epub 2019 Jul 31. Br J Clin Pharmacol. 2019. PMID: 31218733 Free PMC article.

6

Increased delivery of chemotherapy to the vitreous by inhibition of the blood-retinal barrier.

Pascual-Pasto G, Olaciregui NG, Opezzo JAW, Castillo-Ecija H, Cuadrado-Vilanova M, Paco S, Rivero EM, Vila-Ubach M, Restrepo-Perdomo CA, Torrebadell M, Suñol M, Schaiquevich P, Mora J, Bramuglia GF, Chantada GL, Carcaboso AM. Pascual-Pasto G, et al. Among authors: rivero em. J Control Release. 2017 Oct 28;264:34-44. doi: 10.1016/j.jconrel.2017.08.018. Epub 2017 Aug 19. J Control Release. 2017. PMID: 28830790

7

The β 2-Adrenergic Agonist Salbutamol Inhibits Migration, Invasion and Metastasis of the Human Breast Cancer MDA-MB- 231 Cell Line.

Rivero EM, Piñero CP, Gargiulo L, Entschladen F, Zänker K, Bruzzone A, Lüthy IA. Rivero EM, et al. Curr Cancer Drug Targets. 2017;17(8):756-766. doi: 10.2174/1568009617666170330151415. Curr Cancer Drug Targets. 2017. PMID: 28359245

8

Alpha₂-adrenoceptor agonists trigger prolactin signaling in breast cancer cells.

Castillo LF, Rivero EM, Goffin V, Lüthy IA. Castillo LF, et al. Among authors: rivero em. Cell Signal. 2017 Jun;34:76-85. doi: 10.1016/j.cellsig.2017.03.003. Epub 2017 Mar 14. Cell Signal. 2017. PMID: 28302567

9

A Novel Effect of β-Adrenergic Receptor on Mammary Branching Morphogenesis and its Possible Implications in Breast Cancer.

Gargiulo L, May M, Rivero EM, Copsel S, Lamb C, Lydon J, Davio C, Lanari C, Lüthy IA, Bruzzone A. Gargiulo L, et al. Among authors: rivero em. J Mammary Gland Biol Neoplasia. 2017 Mar;22(1):43-57. doi: 10.1007/s10911-017-9371-1. Epub 2017 Jan 11. J Mammary Gland Biol Neoplasia. 2017. PMID: 28074314

10

Reducing High-Risk Drinking Among Student-Athletes: The Effects of a Targeted Athlete-Specific Brief Intervention.

Cimini MD, Monserrat JM, Sokolowski KL, Dewitt-Parker JY, Rivero EM, McElroy LA. Cimini MD, et al. Among authors: rivero em. J Am Coll Health. 2015;63(6):343-52. doi: 10.1080/07448481.2015.1031236. J Am Coll Health. 2015. PMID: 25942068

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20 results

Search Page

Filters